- Combination chemotherapy with vincristine, melphalan and prednisone for multiple myeloma
-
Kim TY, Heo DS, Bang YJ, Park SY, Kim BK, Kim NK, Kim HJ
- KMID: 1698266
- Korean J Med.
- 1993 Jul;45(1):1-11.
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- A Case of Lichen Myxedematosus
-
Lee KB, Cho BK, Houh W
- KMID: 2085647
- Korean J Dermatol.
- 1988 Oct;26(5):697-701.
The patient was a 50 year old woman complaining of generalized multiple pruritic erythematous waxy papules on the face, chest, abdomen, both dorsum of hands and both knee joints areas.... -
- CITED
-
- Close
- SHARE
-
- Close
- Pharmacokinetics of High-dose Intravenous Melphalan in Patients Undergoing Autologous Stem Cell Transplantation
-
Lee SY, Kim JA, Lee JW, Koo HJ, Kim HK
- KMID: 2083509
- Korean J Hematol.
- 2007 Jun;42(2):122-128.
- doi: 10.5045/kjh.2007.42.2.122
BACKGROUND: Melphalan is frequently used in conditioning regimens prior to autologous stem cell transplantation. The pharmacokinetics of melphalan have shown great interindividual variations. This study aims to investigate the pharmacokinetics... -
- CITED
-
- Close
- SHARE
-
- Close
- Therapy-related acute promyelocytic leukemia in plasma cell myeloma treated with melphalan: a case report and literature review
-
Gu H, Kim YJ, Lee WI, Lee J, Yoon HJ, Park TS
- KMID: 2375206
- Blood Res.
- 2017 Mar;52(1):62-64.
- doi: 10.5045/br.2017.52.1.62
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Cutaneous Plasmacytoma Associated with Multiple Myeloma
-
Ahn SK, Lee SH, Shin DH
- KMID: 2231416
- Korean J Dermatol.
- 1987 Dec;25(6):854-857.
A 52-year-old man with multiple myeloma developed cutaneous nodules while being treated with melphalan and prednisolone. A biopsy specimen showed dermal infiltration by well differentiated plasma cells similar to... -
- CITED
-
- Close
- SHARE
-
- Close
- A case of plasmacytoma of the testis associated with multiple myeloma
-
Lee SD, Lee JZ, Yoon JB
- KMID: 2036817
- Korean J Urol.
- 1993 Feb;34(1):176-180.
Extramedullary plasmacytoma of the testis is extremely rare and usually associated with multiple myeloma. A 59-year-old man presented with painless enlargement of his left scrotal content. The initial clinical diagnosis... -
- CITED
-
- Close
- SHARE
-
- Close
- A Case of Papular Mucinosis
-
Song IM, Ihm CW
- KMID: 2116014
- Korean J Dermatol.
- 1997 Oct;35(5):984-988.
Papular mucinosis, also known as lichen myxedematosus or scleromyxedema, is a chronic cutaneous disorder characterizecl by infiltration of mucin in the dermis without abnormalities of thyroid function. It often combines... -
- CITED
-
- Close
- SHARE
-
- Close
- Acute Renal Failure in a Case of Multiple Myeloma
-
Woo TH, Youn SI, Park TW, Chung KS, Kim YS
- KMID: 1677768
- Korean J Urol.
- 1977 Feb;18(1):59-65.
Recently we have experienced a case of multiple myeloma associated with acute renal failure in 42 year-old female patient. The patient does not have specific causes for the acute renal... -
- CITED
-
- Close
- SHARE
-
- Close
- Bortezomib and melphalan as a conditioning regimen for autologous stem cell transplantation in multiple myeloma
-
Lee SR, Kim SJ, Park Y, Sung HJ, Choi CW, Kim BS
- KMID: 2252060
- Korean J Hematol.
- 2010 Sep;45(3):183-187.
- doi: 10.5045/kjh.2010.45.3.183
BACKGROUND: High-dose melphalan (200 mg/m2) with autologous stem cell transplantation (ASCT) is the standard treatment for young patients with multiple myeloma (MM). However, the response rates after ASCT are often... -
- CITED
-
- Close
- SHARE
-
- Close
- Efficacy and Safety of Melphalan, Cyclophosphamide and Dexamethasone (MCD) as a Salvage Treatment for Patients with Relapsed/Refractory Multiple Myeloma
-
Lee SS, Lee JJ
- KMID: 2432252
- Chonnam Med J.
- 2019 Jan;55(1):25-30.
- doi: 10.4068/cmj.2019.55.1.25
This study investigated the efficacy and safety of melphalan, cyclophosphamide, and dexamethasone (MCD) as a salvage regimen for heavily treated relapsed or refractory multiple myeloma patients. We retrospectively analyzed a... -
- CITED
-
- Close
- SHARE
-
- Close
- Modified dose of melphalan-prednisone in multiple myeloma patients receiving bortezomib plus melphalan-prednisone treatment
-
Lee SR, Choi H, Lee BH, Kang KW, Yu ES, Kim DS, Park Y, Choi CW, Kim BS, Sung HJ
- KMID: 2463492
- Korean J Intern Med.
- 2019 Nov;34(6):1333-1346.
- doi: 10.3904/kjim.2018.144
BACKGROUND/AIMS: Bortezomib plus melphalan-prednisone (VMP) is a standard treatment for multiple myeloma, particularly for patients who are ineligible for high-dose therapy. However, early discontinuation or treatment modification is often needed... -
- CITED
-
- Close
- SHARE
-
- Close
- Response and Toxicity of Chemotherapy in 78Cases of Malignant Ovarian Tumors
-
Won JY, Park IS, Hwang SG
- KMID: 1675681
- Korean J Gynecol Oncol Colposc.
- 1996 Jun;7(2):127-134.
For evaluation of the response and toxicity of the combination chemotherapy, forty six patients with malignant ovarian tumors who had prior surgery were treated with combination chemotherapy from January 1985... -
- CITED
-
- Close
- SHARE
-
- Close
- A Preliminary Report of Busulfan, Melphalan and Thiotepa or TBI-containing Bi-alkylator Chemotherapy as a Preparative Regimen for Allogeneic Bone Marrow Transplantation in Refractory or Relapsed Acute Leukemias
-
Kim HJ, Min WS, Park SK, Kim DW, Lee JW, Han CH, Kim CC, Kim DJ
- KMID: 2059155
- J Korean Cancer Assoc.
- 1997 Oct;29(5):874-885.
PURPOSE: We assessed the three-alkylator combination of busulfan, melphalan and thiotepa or TBI, melphalan and thiotepa conditioning for allogeneic stem cell transplantation in 7 adult patients with refractory or relapsed... -
- CITED
-
- Close
- SHARE
-
- Close
- Cutaneous Plasmacytosis Improved by PUVA Therapy
-
Lee Y, Jeon EK, Seo YJ, Park JK, Lee JH, Kim YC
- KMID: 1931120
- Korean J Dermatol.
- 2007 Apr;45(4):378-380.
Cutaneous plasmacytosis is a rare disorder characterized by multiple red-brown plaques, mainly on the trunk, which histologically show a marked hyperplasia of mature plasma cells with no mitotic figures or... -
- CITED
-
- Close
- SHARE
-
- Close
- Busulfan plus melphalan versus high-dose melphalan as conditioning regimens in autologous stem cell transplantation for newly diagnosed multiple myeloma
-
Byun JM, Lee J, Shin SJ, Kang M, Yoon SS, Koh Y
- KMID: 2451027
- Blood Res.
- 2018 Jun;53(2):105-109.
- doi: 10.5045/br.2018.53.2.105
BACKGROUND: High-dose melphalan (HDMEL) represents the standard conditioning regimen before autologous stem cell transplant (ASCT) in multiple myeloma (MM), but recent updates have suggested combination of melphalan with bulsulfan (BUMEL)... -
- CITED
-
- Close
- SHARE
-
- Close
- Enhancement of Cytotoxicity of Chemotherapeutic Agents by Buthionine sulfoximine in Retinoblastoma Cell Line
-
Yang SW, Lee TW, Kim BH, Chang BL
- KMID: 2147771
- J Korean Ophthalmol Soc.
- 1996 Jan;37(1):86-102.
This study was performed to evaluate in vitro cytotoxicity of chemotherapeutic agents in established human retinoblastoma cell line, Y79 and to study the possibility of enhancing the cytotoxicity of chemotherapeutic... -
- CITED
-
- Close
- SHARE
-
- Close
- Normal pregnancy recovered from ovarian failure after multiagent chemotherapy for ovarian carcinoma with positive second-look operation
-
Koo MK, Cho SH, Jo SH, Kim SR, Moon H, Hwang YY
- KMID: 2076240
- Korean J Obstet Gynecol.
- 2001 Apr;44(4):804-807.
We report a successful pregnancy in a woman who at the age of 31years received chemotherapy for mucinous cystadenocarcinoma of the right ovary. She was treated with multiple chemotherapy including... -
- CITED
-
- Close
- SHARE
-
- Close
- Effect of Increased Intracellular pH by HMA on the Cytotoxicity of Combined Treatment of Hyperthermia and Chemotherapy
-
Hur WJ, Song CW
- KMID: 2196685
- J Korean Soc Ther Radiol.
- 1995 Jun;13(2):121-128.
PURPOSE: The enhanced cytotoxic effect of combined treatement of hyperthermia and chemotherapy by increasing intracellular acidify with HMA was investigated. MATERIALS AND METHODS: Fsall tumor cells were injected on the hindlegs... -
- CITED
-
- Close
- SHARE
-
- Close
- Complete Remission in a Patient with Multiple Myeloma after High Dose Melphalan and CD34+ Selected Autologous Transplantation
-
Lee HE, Kim YJ, Kim SG, Kang MB, Kim ST, Kim C, Lee MH, Jue JI, Cho EK, Shin DB, Lee JH
- KMID: 1849154
- Korean J Hematol.
- 1998 Oct;33(3):466-474.
Multiple myeloma is characterized by long clinical course and drug resistance. Conventional chemotherapy results in modest survival benefit. High dose therapy with autologous stem cell transplantation results in markedly increased... -
- CITED
-
- Close
- SHARE
-
- Close
- Advanced POEMS syndrome treated with high-dose melphalan followed by autologous blood stem cell transplantation: a single-center experience
-
Jang IY, Yoon DH, Kim S, Lee K, Kim KK, Lim YM, Min WK, Suh C
- KMID: 2172822
- Blood Res.
- 2014 Mar;49(1):42-48.
- doi: 10.5045/br.2014.49.1.42
BACKGROUND: POEMS syndrome is a rare paraneoplastic syndrome associated with plasma cell dyscrasia. High-dose chemotherapy followed by autologous stem cell transplantation has shown encouraging efficacy in the treatment of patients... -
- CITED
-
- Close
- SHARE
-
- Close
